Vland Biotech's subsidiary receives registration certificates for two joint applications of new veterinary drugs
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Vland Biotech announced that, after review by the Ministry of Agriculture and Rural Affairs, the company's wholly-owned subsidiary Qingdao Kangdien Animal Pharmaceutical Co., Ltd. and other units jointly applied for "Fluralaner Drops (for Dogs)" and "Fluralaner Drops (for Cats)" to be classified as new veterinary drugs of Category II, and the "New Veterinary Drug Registration Certificate" was recently issued
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments